NCCN, ESMO and Cancer Australia recognize scalp cooling as standard of care
National Comprehensive Cancer Network® (NCCN)
- Scalp cooling is a Category 2A recommendation to reduce the incidence of chemotherapy-induced alopecia for patients receiving chemotherapy.
-
For NCCN scalp cooling recommendations view the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
– Breast cancer (Version 1.2019) – Category 2A recommendation
– Ovarian cancer (Version 1.2020) – Category 2A recommendation
European Society for Medical Oncology (ESMO)
- Scalp cooling is a Category IIB treatment recommendation
- Multidisciplinary group of oncology experts from Europe, the United States and Australia authored the recommendation
- ESMO Clinical Practice Guidelines – Prevention and management of dermatological toxicities related to anticancer agents (November 2020)
Cancer Australia
- Fall 2020 update
- Guidance for the management of early breast cancer patients